Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
SNDA
↓ PDF (Pro)Sonida Senior Living Inc. Common Stock
HealthcareMedical Care FacilitiesUnited StatesNYSE
$37.17
-0.27%today
MKT CAP
$1.8B
+10.3% · 1Y
Earnings History
-32.3%
Q4 '25
Analyst Targets
Current price
$37.17
Low
$31.00
Analyst Mean
$35.75
High
$39.00
4 analystsBuy
Full Financials
Trailing P/E-
Forward P/E-83.1x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-2.2%
5y Revenue CAGR-6.1%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership9.9%
Institutional Ownership48.2%
Short % of Float2.65%
Days to Cover1.1d
1 Week+1.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BAILEY TABITHA T. | Officer | Stock | 4,847 | $0.00 | $0.00M | 2026-04-17 |
| RIBAR BRANDON M. | Chief Executive Officer | Stock | 23,023 | $0.00 | $0.00M | 2026-04-17 |
| LEVY MAX | Chief Investment Officer | Stock | 8,482 | $0.00 | $0.00M | 2026-04-17 |
| DETZ KEVIN | Chief Financial Officer | Stock | 12,723 | $0.00 | $0.00M | 2026-04-17 |
| COBER TIMOTHY | Officer | Stock | 3,635 | $0.00 | $0.00M | 2026-04-17 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Conversant Capital LLC | institution | 19.57% | $0.35B | +0.00% | 2025-12-31 |
| Hazelview Securities Inc. | institution | 1.64% | $0.03B | -12.70% | 2025-12-31 |
| Solas Capital Management, LLC | institution | 0.96% | $0.02B | -2.60% | 2025-12-31 |
| Blackrock Inc. | institution | 0.94% | $0.02B | +1.56% | 2025-12-31 |
| Vanguard Group Inc | institution | 0.79% | $0.01B | -13.04% | 2025-12-31 |
| Alyeska Investment Group, L.p. | institution | 0.61% | $0.01B | -43.23% | 2025-12-31 |
| Clayton Partners, LLC | institution | 0.59% | $0.01B | -10.84% | 2025-12-31 |
| Emmett Investment Management, LP | institution | 0.45% | $0.01B | -47.56% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 0.43% | $0.01B | -11.03% | 2025-12-31 |
| Obion Capital Management LP | institution | 0.41% | $0.01B | +100.00% | 2025-12-31 |
| Makena Capital Management, LLC | institution | 0.39% | $0.01B | +0.00% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 0.27% | $0.00B | +0.69% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.17% | $0.00B | -17.36% | 2025-12-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.11% | $0.00B | -1.16% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.08% | $0.00B | -0.36% | 2026-02-28 |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | fund | 0.06% | $0.00B | +1.03% | 2026-02-28 |
| iShares Trust-iShares Russell 2000 Growth ETF | fund | 0.06% | $0.00B | -1.15% | 2026-03-31 |
| iShares Trust-iShares Russell 2000 Value ETF | fund | 0.04% | $0.00B | +0.48% | 2026-03-31 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | fund | 0.03% | $0.00B | +0.00% | 2026-02-28 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.03% | $0.00B | -3.82% | 2026-03-31 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| ADUS | $1.8B | 71 | 18.5 | 13.0 | - | - | - | - | 0.00% |
| MD | $1.8B | 100 | 11.1 | 9.8 | - | - | - | - | 0.00% |
| SGRY | $2.0B | 20 | - | 38.8 | - | - | - | - | 0.00% |
| ASTH | $2.0B | 47 | 77.0 | 11.0 | - | - | - | - | 0.00% |
| SEM | $2.0B | 80 | 15.4 | 11.7 | - | - | - | - | 152.00% |
| HCSG | $1.5B | 60 | 23.0 | 18.9 | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for SNDA.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.